title: [Hormone treatment in the climacteric].
abstract: To improve the quality of life among women during the three decades following the menopause, every effort should be made to prevent the adverse effects of ageing. Broad joint initiatives, involving various disciplines such as, cardiology, urology, oncology, orthopaedics and gynaecology, are needed to optimise medical care during the climacteric. Oestrogen-progesterone treatment is the most important means currently available for the prevention of postmenopausal problems. This form of hormone therapy also appears to provide protection against osteoporosis and cardiovascular disease.
authors.affiliation: Kliniken för obstetrik och gynekologi, Helsingfors Universitescentralsjukhus.
authors.forename: R
authors.initials: R
authors.lastname: Siegberg
authors.forename: F
authors.initials: F
authors.lastname: Pekonen
mesh_terms: D000368:Aged; D002979:Climacteric / Q000187:drug effects*; D003327:Coronary Disease / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause / Q000502:physiology; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control; D011374:Progesterone / Q000008:administration & dosage*; D011788:Quality of Life; D013997:Time Factors
chemical_list: D011374:Progesterone